These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27286240)

  • 1. Measuring the cost of poor asthma control and exacerbations.
    Sullivan PW; Ghushchyan VH; Campbell JD; Globe G; Bender B; Magid DJ
    J Asthma; 2017 Jan; 54(1):24-31. PubMed ID: 27286240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire.
    Sullivan PW; Globe G; Ghushchyan VH; Campbell JD; Bender B; Magid DJ
    Ann Allergy Asthma Immunol; 2016 Sep; 117(3):251-257.e2. PubMed ID: 27613458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation.
    Sullivan PW; Campbell JD; Ghushchyan VH; Globe G; Lange J; Woolley JM
    J Asthma; 2015 Sep; 52(7):669-80. PubMed ID: 25731600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating asthma control questionnaire (ACQ) scores from claims data.
    Sullivan PW; Ghushchyan VH; Globe G
    J Asthma; 2018 Sep; 55(9):1002-1010. PubMed ID: 28976789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of severe asthma exacerbations in Spain: multicentre observational study.
    Quirce S; Melero C; Huerta A; Uría E; Cuesta M
    J Asthma; 2021 Feb; 58(2):207-212. PubMed ID: 31621441
    [No Abstract]   [Full Text] [Related]  

  • 6. Moderate symptom-based exacerbations as predictors of severe claims-based exacerbations in asthma.
    Lane SJ; Petersen H; Seltzer JM; Blanchette CM; Navaratnam P; Allen-Ramey F; Fuhlbrigge A
    J Asthma; 2013 Aug; 50(6):642-8. PubMed ID: 23514102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
    Honkoop PJ; Loijmans RJ; Termeer EH; Snoeck-Stroband JB; van den Hout WB; Bakker MJ; Assendelft WJ; ter Riet G; Sterk PJ; Schermer TR; Sont JK;
    J Allergy Clin Immunol; 2015 Mar; 135(3):682-8.e11. PubMed ID: 25174865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain.
    Sicras-Mainar A; Capel M; Navarro-Artieda R; Nuevo J; Orellana M; Resler G
    J Med Econ; 2020 May; 23(5):492-500. PubMed ID: 31958257
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors Associated with Frequent Exacerbations in the UK Severe Asthma Registry.
    Yang F; Busby J; Heaney LG; Menzies-Gow A; Pfeffer PE; Jackson DJ; Mansur AH; Siddiqui S; Brightling CE; Niven R; Thomson NC; Chaudhuri R;
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2691-2701.e1. PubMed ID: 33460858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the control of severe asthma.
    Hermosa JL; Sánchez CB; Rubio MC; Mínguez MM; Walther JL
    J Asthma; 2010 Mar; 47(2):124-30. PubMed ID: 20170317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.
    Sullivan PW; Ghushchyan VH; Campbell JD; Globe G; Bender B; Magid DJ
    Qual Life Res; 2016 Dec; 25(12):3017-3026. PubMed ID: 27387417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
    Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
    Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
    Stam PJ; van Vliet RC; van de Ven WP
    Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
    Quirce S; Barcina C; Plaza V; Calvo E; Muñoz M; Ampudia R; Capel M
    J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost effectiveness of treatment with salmeterol/fluticasone compared to montelukast for the control of persistent asthma in children].
    Rely K; McQuire SE; Alexandre PK; Escudero GS
    Value Health; 2011; 14(5 Suppl 1):S43-7. PubMed ID: 21839898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic effects of suboptimally controlled asthma.
    Bootman JL; Crown WH; Luskin AT
    Manag Care Interface; 2004 Jan; 17(1):31-6. PubMed ID: 15035598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication use and indicators of poor asthma control in patients with and without allergies.
    Sullivan PW; Lanz MJ; Ghushchyan VH; Kavati A; LeCocq J; Ortiz B; Maselli DJ
    Allergy Asthma Proc; 2019 Jul; 40(4):221-229. PubMed ID: 31053178
    [No Abstract]   [Full Text] [Related]  

  • 20. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S; Cure S; Vogelmeier C; Wirén A
    Int J Clin Pract; 2008 Dec; 62(12):1870-9. PubMed ID: 18803555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.